Next Article in Journal
SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization
Next Article in Special Issue
Safety Monitoring in Clinical Trials
Previous Article in Journal
Composition Influence on Pulmonary Delivery of Rifampicin Liposomes
Previous Article in Special Issue
Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan
Pharmaceutics 2012, 4(4), 607-640; doi:10.3390/pharmaceutics4040607
Review

Signal Detection and Monitoring Based on Longitudinal Healthcare Data

*  and
Received: 4 September 2012; in revised form: 15 November 2012 / Accepted: 26 November 2012 / Published: 13 December 2012
(This article belongs to the Special Issue Drug Safety and Pharmacovigilance)
View Full-Text   |   Download PDF [456 KB, uploaded 13 December 2012]   |   Browse Figures
Abstract: Post-marketing detection and surveillance of potential safety hazards are crucial tasks in pharmacovigilance. To uncover such safety risks, a wide set of techniques has been developed for spontaneous reporting data and, more recently, for longitudinal data. This paper gives a broad overview of the signal detection process and introduces some types of data sources typically used. The most commonly applied signal detection algorithms are presented, covering simple frequentistic methods like the proportional reporting rate or the reporting odds ratio, more advanced Bayesian techniques for spontaneous and longitudinal data, e.g., the Bayesian Confidence Propagation Neural Network or the Multi-item Gamma-Poisson Shrinker and methods developed for longitudinal data only, like the IC temporal pattern detection. Additionally, the problem of adjustment for underlying confounding is discussed and the most common strategies to automatically identify false-positive signals are addressed. A drug monitoring technique based on Wald’s sequential probability ratio test is presented. For each method, a real-life application is given, and a wide set of literature for further reading is referenced.
Keywords: bayesian signal detection; confounder adjustment; disproportionality analysis; longitudinal data; pharmacovigilance; signal detection; spontaneous reporting; surveillance techniques bayesian signal detection; confounder adjustment; disproportionality analysis; longitudinal data; pharmacovigilance; signal detection; spontaneous reporting; surveillance techniques
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Suling, M.; Pigeot, I. Signal Detection and Monitoring Based on Longitudinal Healthcare Data. Pharmaceutics 2012, 4, 607-640.

AMA Style

Suling M, Pigeot I. Signal Detection and Monitoring Based on Longitudinal Healthcare Data. Pharmaceutics. 2012; 4(4):607-640.

Chicago/Turabian Style

Suling, Marc; Pigeot, Iris. 2012. "Signal Detection and Monitoring Based on Longitudinal Healthcare Data." Pharmaceutics 4, no. 4: 607-640.


Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert